SI1833507T1 - Sestavki za imunizacijo proti mikobakterijam - Google Patents
Sestavki za imunizacijo proti mikobakterijamInfo
- Publication number
- SI1833507T1 SI1833507T1 SI200631018T SI200631018T SI1833507T1 SI 1833507 T1 SI1833507 T1 SI 1833507T1 SI 200631018 T SI200631018 T SI 200631018T SI 200631018 T SI200631018 T SI 200631018T SI 1833507 T1 SI1833507 T1 SI 1833507T1
- Authority
- SI
- Slovenia
- Prior art keywords
- antigen
- compositions
- against mycobacterium
- immunizing against
- vector expressing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/08—Antibacterial agents for leprosy
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55588—Adjuvants of undefined constitution
- A61K2039/55594—Adjuvants of undefined constitution from bacteria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/022—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from an adenovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
- C12N2799/023—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a poxvirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2799/00—Uses of viruses
- C12N2799/02—Uses of viruses as vector
- C12N2799/04—Uses of viruses as vector in vivo
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Communicable Diseases (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Virology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Techniques For Improving Reliability Of Storages (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0500102.9A GB0500102D0 (en) | 2005-01-05 | 2005-01-05 | Method for generating a memory t cell response |
US64980405P | 2005-02-03 | 2005-02-03 | |
EP06700223A EP1833507B1 (en) | 2005-01-05 | 2006-01-05 | Compositions for immunizing against mycobacterium |
PCT/GB2006/000023 WO2006072787A1 (en) | 2005-01-05 | 2006-01-05 | Compositions for immunizing against mycobacterium |
Publications (1)
Publication Number | Publication Date |
---|---|
SI1833507T1 true SI1833507T1 (sl) | 2011-07-29 |
Family
ID=34179184
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SI200631018T SI1833507T1 (sl) | 2005-01-05 | 2006-01-05 | Sestavki za imunizacijo proti mikobakterijam |
Country Status (12)
Country | Link |
---|---|
US (1) | US7850979B2 (sl) |
CN (2) | CN102580070A (sl) |
AT (1) | ATE501727T1 (sl) |
DE (1) | DE602006020679D1 (sl) |
DK (1) | DK1833507T3 (sl) |
ES (1) | ES2364698T3 (sl) |
GB (1) | GB0500102D0 (sl) |
PT (1) | PT1833507E (sl) |
RS (1) | RS51815B (sl) |
SI (1) | SI1833507T1 (sl) |
UA (1) | UA93665C2 (sl) |
ZA (1) | ZA200706389B (sl) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ID29858A (id) * | 1998-11-04 | 2001-10-18 | Isis Innovation | Uji diagnostik tuberkulosis |
US20100226998A1 (en) * | 2009-03-05 | 2010-09-09 | Ultradent Products, Inc. | Anti-viral and anti-microbial dental operative material and methods |
MX344052B (es) * | 2009-05-13 | 2016-12-02 | Immport Therapeutics Inc | Composiciones y metodos para antigenos inmunodominantes de mycobacterium tuberculosis. |
PL2654783T3 (pl) * | 2010-12-21 | 2017-08-31 | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. | Rekombinowane Mycobacterium jako szczepionka |
JP2015515276A (ja) * | 2012-04-16 | 2015-05-28 | アエラス グローバル ティービー ワクチン ファウンデーション | ヘパリン結合性赤血球凝集素(hbha)融合タンパク質とその用途をコードする組換え型マイコバクテリウム |
CN102732480A (zh) * | 2012-06-11 | 2012-10-17 | 中山大学 | N-乙酰半胱氨酸对中央记忆性t细胞的绝对数量在体外扩增上的应用 |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030138454A1 (en) * | 1997-06-09 | 2003-07-24 | Oxxon Pharmaccines, Ltd. | Vaccination method |
WO2003047617A2 (en) * | 2001-11-30 | 2003-06-12 | Isis Innovation Limited | Vaccine |
-
2005
- 2005-01-05 GB GBGB0500102.9A patent/GB0500102D0/en not_active Ceased
-
2006
- 2006-01-05 AT AT06700223T patent/ATE501727T1/de active
- 2006-01-05 DK DK06700223.8T patent/DK1833507T3/da active
- 2006-01-05 SI SI200631018T patent/SI1833507T1/sl unknown
- 2006-01-05 ES ES06700223T patent/ES2364698T3/es active Active
- 2006-01-05 US US11/813,397 patent/US7850979B2/en not_active Expired - Fee Related
- 2006-01-05 CN CN2011103023092A patent/CN102580070A/zh active Pending
- 2006-01-05 CN CNA2006800045010A patent/CN101115500A/zh active Pending
- 2006-01-05 RS RS20110238A patent/RS51815B/en unknown
- 2006-01-05 PT PT06700223T patent/PT1833507E/pt unknown
- 2006-01-05 DE DE602006020679T patent/DE602006020679D1/de active Active
- 2006-01-05 UA UAA200707950A patent/UA93665C2/ru unknown
-
2007
- 2007-08-01 ZA ZA200706389A patent/ZA200706389B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
CN101115500A (zh) | 2008-01-30 |
US7850979B2 (en) | 2010-12-14 |
DK1833507T3 (da) | 2011-07-11 |
DE602006020679D1 (de) | 2011-04-28 |
CN102580070A (zh) | 2012-07-18 |
RS51815B (en) | 2011-12-31 |
ZA200706389B (en) | 2008-08-27 |
PT1833507E (pt) | 2011-06-27 |
UA93665C2 (ru) | 2011-03-10 |
ATE501727T1 (de) | 2011-04-15 |
ES2364698T3 (es) | 2011-09-12 |
GB0500102D0 (en) | 2005-02-09 |
US20080226678A1 (en) | 2008-09-18 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2006072787A8 (en) | Compositions for immunizing against mycobacterium | |
Khan | DNA vaccines: roles against diseases | |
Dietrich et al. | Mucosal administration of Ag85B-ESAT-6 protects against infection with Mycobacterium tuberculosis and boosts prior bacillus Calmette-Guerin immunity | |
Delany et al. | Vaccines for the 21st century | |
da Costa et al. | Tuberculosis vaccines–state of the art, and novel approaches to vaccine development | |
Zheng et al. | Applications of bacillus Calmette–Guerin and recombinant bacillus Calmette–Guerin in vaccine development and tumor immunotherapy | |
Roohvand et al. | Advances in hepatitis C virus vaccines, part two: advances in hepatitis C virus vaccine formulations and modalities | |
ZA200706389B (en) | Compositions for immunizing against mycobacterium | |
TW200722101A (en) | Novel composition | |
GB2434367A (en) | Improved vaccines | |
TW200637910A (en) | Recombinant BCG strains with enhanced ability to escape the endosome | |
MXPA05013973A (es) | Metodos para producir, mejorar y sustentar respuestas inmunes contra epitopes restringidos mhc clase i, para propositos profilacticos o terapeuticos. | |
BR0311995A (pt) | Partìculas semelhantes a vìrus empacotadas para o uso como adjuvantes: método de preparação e uso | |
EP2385060A3 (en) | Methods and compositions to elicit multivalent immune responses against dominant and subdominant epitopes, expressed on cancer cells and tumor stroma | |
MX2023006203A (es) | Vacunas novedosas contra el virus de zika. | |
WO2006095330A3 (en) | Methods and immunogenic cell preparations for treating antigen-associated diseases | |
WO2008019366A3 (en) | Methods and compositions for increased priming of t-cells through cross-presentation of exogenous antigens | |
WO2002061113A3 (en) | Nucleic acid derived vaccine that encodes an antigen linked to a polypeptide that promotes antigen presentation | |
SG158154A1 (en) | Methods to elicit, enhance and sustain immune responses against mhc class i-restricted epitopes, for prophylactic or therapeutic purposes | |
WO2008057235A3 (en) | Enhanced immunogenicity of tumor associated antigens by addition of alphagal epitopes | |
Excler et al. | Lessons from HIV-1 vaccine efficacy trials | |
Plotkin | Six revolutions in vaccinology | |
WO2004043399A3 (en) | Methods and compositions for inducing immune responses and protective immunity by priming with alphavirus replicon vaccines | |
Soundarya et al. | Current trends in tuberculosis vaccine | |
WO2003085098A3 (en) | Identification of virulence associated regions rd1 and rd5 enabling the development of improved vaccines of m. bovis bcg and m. microti |